INVESTOR LOGIN

LRG BayStar Capital Funds Portfolio

PORTFOLIO COMPANIES

Please find some the portfolio of current and prior LRG BayStar Capital Funds' portfolio companies below:

Neose Technologies, Inc. (NTEC)

Neose Technologies, Inc. (NTEC)

Neose is a biopharmaceutical company focused on the improvement of protein therapeutics through the application of its proprietary technologies for improved safety and efficacy.
 
  http://www.neose.com

Neurobiological Technologies, Inc. (NTII)

Neurobiological Technologies, Inc. (NTII)

Neurobiological Technologies Inc. is an emerging drug development company focused on the clinical development and regulatory approval of neuroscience drugs. http://www.ntii.com

NexMed, Inc. (NEXM)

NexMed, Inc. (NEXM)

NexMed, Inc. is a pharmaceutical and medical technology company that develops and commercializes therapeutic products based on its proprietary transdermal drug delivery systems.
http://www.nexmed.com

NPS Pharmaceuticals, Inc. (NPSP)

NPS Pharmaceuticals, Inc. (NPSP)

NPS Pharmaceuticals is engaged in the discovery and development of small molecule drugs that are intended to address a variety of important diseases, including hyperparathyroidism, osteoporosis, and various CNS disorders.
  http://www.npsp.com

Orchid Biosciences, Inc. (ORCH)

Orchid Biosciences, Inc. (ORCH)

Orchid Biosciences, Inc., now Orchid Cellmark, Inc., is the leading provider of products and services for the profiling of genetic uniqueness.
http://www.orchid.com

 
Arque Capital
This website is for general informational purposes only and is not intended as a solicitation or offering for any investment product or service.
LRG Capital Group, in alliance with Arque Capital, Ltd. Member FINRA/SIPC